X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
research (4) 4
care and treatment (3) 3
oncology (3) 3
adult (2) 2
aged (2) 2
breast cancer (2) 2
cancer (2) 2
cancer therapies (2) 2
diagnosis (2) 2
female (2) 2
health risk assessment (2) 2
hematology (2) 2
hematology, oncology and palliative medicine (2) 2
humans (2) 2
index medicus (2) 2
male (2) 2
mammography (2) 2
middle aged (2) 2
patient outcomes (2) 2
prognosis (2) 2
skin and connective tissue diseases (2) 2
treatment outcome (2) 2
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - pathology (1) 1
adolescent (1) 1
amg 102 (1) 1
amplification (1) 1
analysis (1) 1
anthracyclines (1) 1
antibiotics (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
aprepitant (1) 1
article subject (1) 1
bilateral breast cancer (1) 1
bm parameters (1) 1
body mass index (1) 1
bone marrow (1) 1
bone marrow - metabolism (1) 1
c-met (1) 1
capecitabine (1) 1
carcinoma (1) 1
case report (1) 1
chemotherapy (1) 1
circulating level (1) 1
cisplatin - adverse effects (1) 1
cisplatin - therapeutic use (1) 1
clinical outcomes (1) 1
clinical study (1) 1
cml (1) 1
cml patients (1) 1
comparative analysis (1) 1
complications and side effects (1) 1
confidence intervals (1) 1
cytogenetic response (1) 1
deoxycytidine - adverse effects (1) 1
deoxycytidine - analogs & derivatives (1) 1
deoxycytidine - therapeutic use (1) 1
diagnosed chronic-phase (1) 1
disease-free survival (1) 1
dosage and administration (1) 1
dose-response relationship, drug (1) 1
double-blind method (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
economic aspects (1) 1
epirubicin - adverse effects (1) 1
epirubicin - therapeutic use (1) 1
esophagogastric junction - drug effects (1) 1
esophagogastric junction - pathology (1) 1
eutos score (1) 1
expression (1) 1
family medical history (1) 1
febrile neutropenia (1) 1
fever (1) 1
fluorouracil - adverse effects (1) 1
fluorouracil - analogs & derivatives (1) 1
fluorouracil - therapeutic use (1) 1
follow-up (1) 1
gene amplification (1) 1
gene-expression (1) 1
genes (1) 1
gimema working party (1) 1
gram-negative organism (1) 1
guidelines (1) 1
health care (1) 1
hematological malignancies (1) 1
hepatocyte growth-factor (1) 1
imatinib mesylate - pharmacology (1) 1
imatinib mesylate - therapeutic use (1) 1
insulin (1) 1
leucocytes (1) 1
leukemia (1) 1
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (1) 1
leukemia, myelogenous, chronic, bcr-abl positive - pathology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 1007 - 1018
Summary Background Dysregulation of the hepatocyte growth factor (HGF)/MET pathway promotes tumour growth and metastasis. Rilotumumab is a fully human,... 
Hematology, Oncology and Palliative Medicine | AMPLIFICATION | PHARMACOKINETICS | ONCOLOGY | HEPATOCYTE GROWTH-FACTOR | C-MET | MONOCLONAL-ANTIBODY | CIRCULATING LEVEL | AMG 102 | CANCER | EXPRESSION | CARCINOMA | Confidence Intervals | Adenocarcinoma - pathology | Esophagogastric Junction - drug effects | Prognosis | Capecitabine | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Stomach Neoplasms - pathology | Dose-Response Relationship, Drug | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Fluorouracil - adverse effects | Neoplasm Invasiveness - pathology | Adult | Deoxycytidine - adverse effects | Female | Double-Blind Method | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Proportional Hazards Models | Esophagogastric Junction - pathology | Survival Rate | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Epirubicin - therapeutic use | Aged | Neoplasm Staging | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Epirubicin - adverse effects | Monoclonal antibodies | Anthracyclines | Index Medicus
Journal Article
Journal of laboratory physicians, ISSN 0974-2727, 07/2015, Volume 7, Issue 2, pp. 116 - 120
Febrile neutropenia (FN) is considered a medical emergency. Patients with hematological malignancies (HM) commonly experience FN. Broad spectrum antibiotics... 
Care and treatment | Diagnosis | Patient outcomes | Neutropenia | Leucocytes | Hematology | Microbiology | Leukemia | Fever | Clinical outcomes | hematological malignancies | treatment | Gram-negative organism | febrile neutropenia | Antibiotics | Original
Journal Article
Hereditary Cancer in Clinical Practice, ISSN 1731-2302, 02/2014, Volume 12, Issue 1, pp. 5 - 5
The association of neurofibromatosis type I with invasive male breast cancer is a rare clinical entity with only one case in literature reported in 1953. Women... 
NF1 | TUMOR | ONCOLOGY | GENES
Journal Article
Indian Journal of Medical and Paediatric Oncology, ISSN 0971-5851, 01/2018, Volume 39, Issue 1, pp. 58 - 61
Background: Bilateral breast cancer (BBC) is a rare clinical entity with limited data regarding clinicopathological aspects and treatment guidelines. Materials... 
synchronous breast cancer | metachronous breast cancer is | Bilateral breast cancer | Care and treatment | Breast cancer | Diagnosis | Research | Patient outcomes | Health care | Pathology | Mastectomy | Mammography | Family medical history | Health risk assessment | Cancer therapies | Guidelines
Journal Article
Journal Article
ecancermedicalscience, ISSN 1754-6605, 06/2018, Volume 12, p. 845
Breast cancer is a heterogeneous disease which is divided broadly into luminal, HER2 and basal type based on molecular profiling. Increased body mass index... 
Body Mass Index | Breast Cancer | Studies | Body mass index | Obesity | Weight control | Womens health | Mammography | Breast cancer | Health risk assessment | Patients | Insulin
Journal Article
Chemotherapy research and practice, ISSN 2090-2107, 2016, Volume 2016, pp. 3439707 - 5
Background. The efficacy, safety, and cost benefit of olanzapine (OLN) when compared to aprepitant (APR) in the prevention of chemotherapy induced nausea and... 
Aprepitant | Complications and side effects | Chemotherapy | Olanzapine | Economic aspects | Dosage and administration | Research | Comparative analysis | Cancer | Clinical Study
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.